Blackstone, KKR and other investors are betting on laboratory space as vaccines fuel the economic rebound.
More than 10 billion dollars has now gone towards buying buildings used for life sciences and other research so far this year and that accounts for about 4 percent of all global commercial real estate deals through May.
That’s twice last year’s share of Blackstone. KKR and other investors are betting on laboratory space for example. And this chart just goes to show U.S. office vacancies at the highest on record. The traditional offices like these are expected to take a lot of time as companies call employees back over the next few months. It has raised questions though about the future of traditional downtown skyscrapers particularly and also in Europe as they deal with this more of a hybrid kind of model.
Source: Yahoo Finance
Can’t stop reading? Read more
US Pipeline Operator ONEOK Inks Two Deals for $5.9 Billion
US pipeline operator ONEOK Inc. agreed to buy a Permian Basin rival and a controlling stake in...
Blackstone Is Said to Seek A$5.5 Billion Loan for AirTrunk Bid
Private equity firm Blackstone Inc. is in discussions with banks for a five-year loan of about...
Thrive Capital to lead multi-billion dollar OpenAI investment round at $100bn valuation
OpenAI, the company behind the popular AI tool ChatGPT, is in advanced talks to secure several...